Italia markets open in 4 hours 6 minutes

JNJ Jun 2024 200.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
2,50000,0000 (0,00%)
In data: 09:30AM EDT. Mercato aperto.
Schermo intero
Chiusura precedente2,5000
Aperto2,5000
Denaro0,0000
Lettera2,1300
Prezzo d'esercizio200,00
Scadenza2024-06-14
Min-Max giorno2,5000 - 2,5000
Contratto - Min-MaxN/D
Volume8
Open Interest5
  • GlobeNewswire

    Alvotech and Teva Secure U.S. License Date for AVT04, a Proposed Biosimilar to Stelara®

    According to the settlement agreement, AVT04 (ustekinumab) can be marketed in the US, subject to regulatory approval, no later than February 21, 2025 REYKJAVIK, Iceland and TEL AVIV, Israel and PARSIPPANY, N.J., June 12, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA